Head-to-head · WeighScore
CoreAge Rx vs Sprout Health
The verdict
CoreAge Rx takes it — 89.5/100 to 79.8/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | Sprout Health |
|---|---|---|
| WeighScore | 89.5/100 | 79.8/100 |
| Grade | B+ | C+ |
| Site position | #1 | #26 |
| Semaglutide | $99/mo | $299/mo |
| Tirzepatide | $149/mo | $349/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #1 · B+
Strengths
- Advertises the same medication price at every dose
- Semaglutide and tirzepatide injection options
- No membership fee; standard prescription shipping included unless checkout states otherwise
Where it loses points
- Compounded only; no FDA-approved brand option listed
- Dispensing pharmacy not identified on the reviewed product pages
- Applicable $50–$100 consultation fee is nonrefundable after review begins
- Orders become final after approval and pharmacy transmission; 30-day refund cutoff also applies
Site position #26 · C+
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Strengths
- LegitScript-certified with a listed address and contact line
- Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
- Low-friction intake — no labs and often no telehealth visit required
Where it loses points
- Compounded semaglutide and tirzepatide are not FDA-approved
- No oral or sublingual route — injectable only
- Thin transparency — no named medical director, and state availability is quiz-gated
- "No labs, no visit" convenience also means lighter clinical oversight
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.